Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Lamattina John L
Over the trailing 90 days, Lamattina John L (Director at LIGAND PHARMACEUTICALS INC) sold $1.2M of stock in LGND, per 6 SEC Form 4 transactions.
- Role
- Director
- Companies
- LGND
- Window
- Trailing 90 days · 6 transactions · CIK 1216074
- Net activity
- −$1.2M ($0 bought · $1.2M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | 6 | — | $1.2M | −$1.2M |
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-10 | LGND | Sell | 232 | $58K | Open market or private sale |
| 2026-06-10 | LGND | Sell | 257 | $64K | Open market or private sale |
| 2026-06-10 | LGND | Sell | 3.4K | $857K | Open market or private sale |
| 2026-06-10 | LGND | Sell | 697 | $174K | Open market or private sale |
| 2026-06-05 | LGND | Buy | 2.9K | $0 | Grant, award or other acquisition |
| 2026-06-05 | LGND | Buy | 836 | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Lamattina's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.